Contact Philippe Nore
Title CEO and Co-founder


MiNDERA is developing a breakthrough technology to extract skin biomarkers in a non-invasive manner (no biopsy required). At the core of our products is a proprietary micro-needle array devices that enables pain free, non-invasive and targeted extraction of biomarkers from the skin (e.g. mRNA), without requiring a skin biopsy. These biomarkers are then eluted and analyzed by molecular techniques including PCR and next-generation sequencing to deliver a molecular profile of the sampled region.

Company News

Mindera Raises Over $12M Series A-2 Financing

DateMay 12, 2021
Mindera Corporation today announced a $12.6M Series A-2 capital raise. The round was led by Mountain Group Partners, Rockmont Investments, and Scientific Health Development.
Read More →

MiNDERA selected to present at BIOVISION Conference

DateApr 7, 2016
MiNDERA has been selected as one of the emerging companies that will present at the BIOVISION Investor Conference to be held on April 13 and 14 2016 in Lyon, France.

MiNDERA Corp closes Seed round and adds Andrew Offer to its Board

DateOct 12, 2015
MiNDERA Corp. announces the close of its $1 million Seed financing round. Also, Andrew Offer, Managing Director at Scientific Health Development will be joining MiNDERA's Board of Directors following SHD's investment in the company.

Mindera nominated for 2015 Diagnostics Startup of the Year

DateAug 27, 2015
Diassess, Bikanta, Privail, and Mindera are nominated for the QB3 2015 Diagnostics Startup of the Year Award.